Madrigal Pharmaceuticals, Inc. MDGL Geographic — Operating lease, liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s geographic — operating lease, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s geographic — operating lease, liability?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported geographic — operating lease, liability of $4.6M in Q1 2026.
- What does geographic — operating lease, liability mean?
- The total present value of future rent payments owed for the company's leased facilities in West Conshohocken, Pennsylvania.
- How do you interpret geographic — operating lease, liability?
- An increase suggests higher future cash outflows due to new leases or extensions, whereas a decrease indicates the reduction of debt-like obligations through scheduled payments or lease terminations.
- How does geographic — operating lease, liability compare across companies?
- Similar to other clinical-stage biotech firms, this liability is comparable to other long-term facility obligations and is evaluated by investors to assess the company's burn rate and fixed cost structure.